CJC-1295 10mg
CJC-1295 is a synthetic peptide analogue studied within laboratory environments for its interaction with growth hormone–releasing hormone (GHRH) pathways and associated regulatory systems. It is designed to extend the activity of GHRH through structural modification.
In research settings, CJC-1295 is investigated for its role in receptor-mediated signalling linked to growth hormone regulation and hypothalamic–pituitary axis activity. Ongoing studies explore its interaction with GHRH receptors and its relevance in prolonged signalling dynamics within endocrine research models.
This compound is supplied as a lyophilized powder, manufactured to meet high standards of purity, structural integrity, and batch consistency, supporting controlled and reproducible research applications.
For research purposes only. Not for human consumption.
Compound Specifications
| Purity | ≥98% (HPLC) |
| Molecular Formula | C₁₆₅H₂₆₉N₄₇O₄₆ |
| Molecular Weight | 3,647.3 g/mol |
| CAS Number | 863288-34-0 |
| Amino Acid Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ |
Protocols
Our research protocols is structured to ensure consistency, reproducibility, and compliance within your research standards.
Need guidance on protocol design or implementation? Our consultation services provide expert support tailored to your research objectives.